CIK 0001832511 · Non-accelerated filer<br>Smaller reporting company
P3 Health Partners Inc.
Sign in to watch- Ticker
- PIII
- Exchange
- Nasdaq
- Industry
- Services-Health Services
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 852992794
- Phone
- 312-822-8897
- Business address
- 2045 W GRAND AVE STE B, PMB # 82152, CHICAGO, IL, 60612-1577
- Former names
- Foresight Acquisition Corp.
Securities
- PIII Class A Common Stock Nasdaq
- PIIIW Warrant Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-04-06 | Chicago Pacific Founders UGP, LLC 10% owner | Purchase · Common Stock Purchase Warrant | +4,279,031 | 4,708,211 | ||
| 2023-04-06 | Chicago Pacific Founders UGP, LLC 10% owner | Purchase · Pre-Funded Common Stock Purchase Warrant | +966,253 | 966,253 | ||
| 2023-04-06 | LEAVITT LEGACY, LLC 10% owner | Grant or award | +8,944,543 | 8,944,543 | ||
| 2023-04-06 | LEAVITT LEGACY, LLC 10% owner | Grant or award | +894,454 | 894,454 | ||
| 2023-04-06 | LEAVITT LEGACY, LLC 10% owner | Grant or award · Warrant | +6,708,407 | 6,708,407 | ||
| 2023-04-06 | LEAVITT LEGACY, LLC 10% owner | Grant or award · Warrant | +670,841 | 670,841 | ||
| 2023-04-06 | Bacchus Amir Chief Medical Officer | Grant or award | +1,005,193 | 1,005,193 | ||
| 2023-04-06 | Bacchus Amir Chief Medical Officer | Grant or award | +251,298 | 251,298 | ||
| 2023-04-06 | Bacchus Amir Chief Medical Officer | Grant or award · Warrant | +753,895 | 753,895 | ||
| 2023-04-06 | Bacchus Amir Chief Medical Officer | Grant or award · Warrant | +188,474 | 188,474 | ||
| 2022-12-13 | Chicago Pacific Founders UGP, LLC 10% owner | Purchase · Warrant to Purchase Class A Common Stock | +429,180 | 429,180 | ||
| 2022-12-12 | Kavthekar Atul Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +600,000 | 600,000 | ||
| 2022-11-28 | Darakjian Erin Interim CFO, Senior VP & CAO | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2022-03-24 | WASSON GREGORY D Director | Grant or award · Stock Option (Right to Buy) | +85,535 | 85,535 | ||
| 2022-03-24 | TOLAN MARY A Director | Grant or award · Stock Option (Right to Buy) | +85,535 | 85,535 | ||
| 2022-03-24 | Thierer Mark Director | Grant or award · Stock Option (Right to Buy) | +171,069 | 171,069 | ||
| 2022-03-24 | Thierer Mark Director | Grant or award · Stock Option (Right to Buy) | +200,000 | 200,000 | ||
| 2022-03-24 | Price Thomas Edmunds Director | Grant or award · Stock Option (Right to Buy) | +85,535 | 85,535 | ||
| 2022-03-24 | Park Jeffrey G Director | Grant or award · Stock Option (Right to Buy) | +85,535 | 85,535 | ||
| 2022-03-24 | Leisure Lawrence B. Director | Grant or award · Stock Option (Right to Buy) | +85,535 | 85,535 |
Page 6 of 9 · 166 trades